- Report
- February 2024
- 175 Pages
Global
From €4789EUR$5,000USD£4,078GBP
- Report
- January 2024
- 175 Pages
Global
From €4789EUR$5,000USD£4,078GBP
- Report
- November 2023
- 178 Pages
Global
From €4693EUR$4,900USD£3,997GBP
- Clinical Trials
- April 2024
- 80 Pages
Global
From €1916EUR$2,000USD£1,631GBP
- Report
- January 2024
- 143 Pages
Global
From €4071EUR$4,250USD£3,466GBP
- Report
- April 2023
- 105 Pages
Global
From €4550EUR$4,750USD£3,874GBP
- Drug Pipelines
- August 2022
- 60 Pages
Global
From €1197EUR$1,250USD£1,020GBP
- Drug Pipelines
- December 2022
- 127 Pages
Global
From €10531EUR$10,995USD£8,968GBP
- Report
- April 2023
- 94 Pages
Global
From €3500EUR$3,915USD£3,085GBP
- Report
- July 2021
- 94 Pages
Global
From €3200EUR$3,579USD£2,820GBP
- Report
- January 2021
- 140 Pages
China, Global
From €3000EUR$3,355USD£2,644GBP
- Report
- May 2024
- 50 Pages
Global
From €2538EUR$2,650USD£2,161GBP
- Report
- December 2022
- 220 Pages
Global
From €3419EUR$3,570USD£2,912GBP
Norethisterone is a synthetic progestogen used in the treatment of various sexual and reproductive health conditions. It is used to treat menstrual disorders, endometriosis, and abnormal uterine bleeding. It is also used as a contraceptive, either alone or in combination with an estrogen. Norethisterone is available in a variety of formulations, including tablets, injections, and implants.
Norethisterone is a widely used drug in the sexual and reproductive health market. It is used to treat a variety of conditions, and is available in a range of formulations. It is also used as a contraceptive, either alone or in combination with an estrogen.
Some companies in the Norethisterone market include Bayer, Pfizer, Merck, and Teva Pharmaceuticals. Show Less Read more
